Pharming Group

$0.00 (0.00%) As of 8:05 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharming Group and other ETFs, options, and stocks.

About PHAR

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.

CEO
Sijmen de Vries
Employees
—
Headquarters
Leiden, Zuid-Holland
Founded
1988

PHAR Key Statistics

Market cap
512.24M
Price-Earnings ratio
45.46
Dividend yield
—
Average volume
4.40K
High today
$8.10
Low today
$7.25
Open price
$7.41
Volume
1.67K
52 Week high
$11.73
52 Week low
$6.10

PHAR Earnings

-$0.00
$0.01
$0.01
$0.02
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure